SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000898432-06-000317
Filing Date
2006-03-28
Accepted
2006-03-28 11:26:49
Documents
2
Group Members
BIOTECHNOLOGY VALUE FUND II, L.P.BVF INC.BVF INVESTMENTS, L.L.C.BVF PARTNERS L.P.INVESTMENT 10, L.L.C.

Document Format Files

Seq Description Document Type Size
1 bvf-valentis_sc13g.htm SC 13G 106096
2 exhibit_99.htm EX-99 12914
  Complete submission text file 0000898432-06-000317.txt   121299
Mailing Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606
Business Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606 415-288-23
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6282 Investment Advice

Mailing Address 863A MITTEN ROAD BURLINGAME CA 94010
Business Address 863A MITTEN RD BURLINGAME CA 94010 6506971900
VALENTIS INC (Subject) CIK: 0000932352 (see all company filings)

IRS No.: 943156660 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SC 13G | Act: 34 | File No.: 005-53479 | Film No.: 06713958
SIC: 2836 Biological Products, (No Diagnostic Substances)